GlassScriptPhysician profile
Leyla J Ghazi
NPI 1114135498
$811.70
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $17.39 · 2021: $15.57 · 2022: $191 · 2023: $262 · 2024: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $410.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $410.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $429.64 | 2022-2024 | |
| Pfizer INC. | $80.91 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $59.01 | 2019-2023 | Dificid |
| Gilead Sciences, INC. | $48.68 | 2023-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.67 | 2019-2024 | Entyvio |
| Janssen Biotech, INC. | $37.98 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.66 | 2019-2021 | |
| Ardelyx, INC. | $31.92 | 2024 | Ibsrela |
| Celgene Corporation | $24.15 | 2022 | |
| Shire North American Group INC | $23.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leyla Ghazi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.